Journal of Immunology and Immunopathology
  • Year: 2010
  • Volume: 12
  • Issue: 2

IBT/031 Synergestic Effect of HN Gene of NDV and TNF-alpha in Oncolysis of Experimentally Induced Tumor in Rat

  • Author:
  • R.S. Rajmani, Juwar Doley, Prafull K Singh, A.P. Sahoo, G Ravi Kumar, Lovleen Saxena, Uttara Chaturvedi, Shikha Saxena, P.C. Verma, Ashok. K. Tiwari

Molecular Biology Laboratory, Division of Animal Biotechnology,Indian Veterinary Research Institute, Izatnagar-243 122.

Abstract

HN gene of NDV is known to possess the inherent ability to induce apoptosis in transformed cells. It is reported that HN is a potent inducer of interferons and capable of upregulating the TNFα related apoptosis inducing ligand (TRAIL). Tumor necrosis factor-alpha has been shown to exhibit direct anti tumor activity, killing some tumor cells and reducing the rate of proliferation of others while sparing normal cells. TNF-α is an important regulator of immune response that influences cell differentiation, survival and apoptosis. Apoptotic response of TNF-α is mediated by the activation of caspase-8. In the present study, the HN gene of Newcastle disease virus and TNF-α of rat were cloned with Kozak sequence for better expression in eukarayotic expression vector pcDNA 3.1(+). For the assessment of oncolytic effect of HN and TNF-α, skin tumor were induced (papilloma and squamous cell carcinoma) in 30 male wistar rats (age 6–7 weeks) by applying 1% DMBA (7, 12dimethyl benz (a) anthracene, M.W.-256.3, Sigma USA) topically on shaved skin of hind back region of rats. In 3 to 5 months, all rats developed benign tumor (papilloma like growth) and squamous cell carcinoma. The rats were grouped in 5 groups viz I, II, III, IV and V (having 6 rats in each group). The recombinant pcDNA-hn-Kozak was treated intratumorally @100 μg/rat in group I. and group II rats were treated with pcDNA.TNF-α Kozak. The group III rats were treated with both the recombinant clones. The group IV rats were taken as vector control (pcDNA 3.1(+) @100 μg/rat) while group V was taken as mock control (treated with PBS alone). Two rats from each group were sacrificed humanely at day 3, 7 and 14 post treatment. Spleen, peripheral blood and tumor tissues were collected from these rats for the assessment of immune response and oncolytic effect by assessing proliferation of CD4+, CD8+ and NK cells (Flow cytometry, immunohistochemistry and histopathology). The flow cytometry analysis showed a significant increase in CD4+ CD8+ and NK cell population in group III followed by group I and II while there was no significant increase in group IV and V. Immunohistochemistry and histopathological analysis of tumor tissues also revealed the synergestic effect of HN and TNF-alpha in oncolysis. Further studies are being designed to assess the expression pattern of different cytokines in in vivo tumor model after treatment with recombinant pcDNA nd.hn-Kozak and pcDNA rat INFα -Kozak in combination.